| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $217 | +0.0% |
| R&D Expense | $232K | +39.8% |
| SG&A Expense | $1.8M | +56.7% |
| Operating Income | -$1.8M | -36.7% |
| Interest Expense | $92K | +61.9% |
| Pre-tax Income | -$2.2M | +26.7% |
| Net Income | -$2.2M | +25.9% |
| EPS (Basic) | -$0.01 | +50.0% |
| EPS (Diluted) | -$0.01 | +50.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | -100.0% |
| Inventory | $5K | +48.6% |
| Current Assets | $238K | +20.7% |
| Total Assets | $248K | +25.3% |
| Current Liabilities | $4.6M | +80.0% |
| Total Liabilities | $4.6M | +80.0% |
| Stockholders' Equity | -$4.4M | -84.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$645K | +2.3% |
| Investing Cash Flow | -$9K | — |
| Financing Cash Flow | $647K | +15.9% |